Remove 2028 Remove FDA Remove Pharmaceutical Companies
article thumbnail

Eliquis generic availability, cost, and dosage

The Checkup by Singlecare

Food and Drug Administration (FDA) in 2012 as a brand-name drug. Although a generic was approved in 2019, generic apixaban will not be available on the market until at least April 2028. The FDA approved two applications for generic versions of Eliquis by the companies Micro Labs Limited and Mylan Pharmaceuticals, Inc.

Dosage 52
article thumbnail

After rebuffing Biogen, Sage pairs off with Supernus

pharmaphorum

Skip to main content Monday 16 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

M&A outlook for pharma in 2025

European Pharmaceutical Review

For instance, patent expiries are set to wipe out $300 billion in revenues by 2028. With growing emergence of AI into 2025, the first part of the year saw the US Food and Drug Administration (FDA) issue draft recommendations on AI, which are set to address the safety, effectiveness or quality of drugs or biological products.

article thumbnail

RFK Jr axes vaccine advisory committee members

Pharmaceutical Technology

Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028, RFK Jr wrote. He noted that these conflicts of interest continue to the current day, with ACIP members receiving substantial funding from pharmaceutical companies.